iCAD Schedules Third Quarter Conference Call for Thursday, October 27, 2005
21 Octobre 2005 - 7:00PM
PR Newswire (US)
NASHUA, N.H., Oct. 21 /PRNewswire-FirstCall/ -- iCAD(R), Inc.
(NASDAQ: ICAD), an industry-leading provider of Computer-Aided
Detection (CAD) solutions for the early identification of cancer,
today announced that W. Scott Parr, President and CEO of iCAD,
Inc., will discuss the Company's results for the quarter ended
September 30, 2005, during a conference call scheduled for
Thursday, October 27, 2005, at 11:00am ET. The Company's financial
results for the third quarter are scheduled to be released earlier
that day. Shareholders and other interested parties may participate
in the conference call by dialing +1 866 713 8307 (domestic) or +1
617 597 5307 (international) and entering passcode 42833782, a few
minutes before 11:00am ET on October 27, 2005. The call will also
be broadcast live on the Internet at http://www.streetevents.com/,
http://www.fulldisclosure.com/ or http://www.icadmed.com/. A replay
of the conference call will be accessible two hours after its
completion through November 3, 2005 by dialing +1 888 286 8010
(domestic) or +1 617 801 6888 (international) and entering passcode
74745312. The call will also be archived for 90 days at
http://www.streetevents.com/, http://www.fulldisclosure.com/ and
http://www.icadmed.com/. About iCAD, Inc. iCAD, Inc. is an
industry-leading provider of Computer-Aided Detection (CAD)
solutions that enable healthcare professionals to identify cancer
and other life-threatening conditions earlier by making medical
services more effective, more accessible and more affordable for
patients worldwide. Recipient of Frost & Sullivan's Growth
Strategy Leadership award, iCAD offers a comprehensive range of
high-performance, upgradeable CAD systems for the high, mid and low
volume mammography markets. iCAD is entrusted with the task of
early cancer detection by over eleven hundred women's healthcare
centers worldwide. For more information, call +1 877 iCADnow or
visit http://www.icadmed.com/. iCAD is a registered trademark of
iCAD, Inc. For iCAD investor relations, contact Kevin McGrath of
Cameron Associates at +1 212 245 4577 or via email at . DATASOURCE:
iCAD, Inc. CONTACT: Kevin McGrath of Cameron Associates,
+1-212-245-4577, Web site: http://www.icadmed.com/
http://www.fulldisclosure.com/ http://www.streetevents.com/
Copyright